Prestige Consumer Healthcare
PBH
#3858
Rank
NZ$5.47 B
Marketcap
NZ$111.30
Share price
3.97%
Change (1 day)
-16.85%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$7.02

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.75. In 2024 the company made an earnings per share (EPS) of NZ$7.14 an increase over its 2023 EPS that were of NZ-$2.68.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$7.02-1.72%
2024NZ$7.14-367.08%
2023NZ-$2.68-138.33%
2022NZ$6.9811.7%
2021NZ$6.2513.6%
2020NZ$5.50-651.67%
2019NZ-$1.00-148.78%
2018NZ$2.04-83.29%
2017NZ$12.23437.23%
2016NZ$2.28-34.13%
2015NZ$3.4652.94%
2014NZ$2.26-8.11%
2013NZ$2.46
2011NZ$1.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.35 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$11.68 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.23 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.39 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.65 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$0.66-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$49.21-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.03-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel